DNA methylation in promoter regions of genes involved in the reproductive and metabolic function of children born to women with PCOS

References

• Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5):270–284.
   PubMed Web of Science ®Google Scholar
• Sir-Petermann T, Hitchsfeld C, Maliqueo M, et al. Birth weight in offspring of mothers with polycystic ovarian syndrome. Hum Reprod. 2005;20(8):2122–2126.
   PubMed Web of Science ®Google Scholar
• Vanky E, Engen Hanem LG, Abbott DH. Children born to women with polycystic ovary syndrome-short- and long-term impacts on health and development. Fertil Steril. 2019;111(6):1065–1075.
   PubMed Web of Science ®Google Scholar
• Maliqueo M, Echiburu B, Crisosto N, et al. Metabolic parameters in cord blood of newborns of women with polycystic ovary syndrome. Fertil Steril. 2009;92(1):277–282.
   PubMed Web of Science ®Google Scholar
• Chakrabarti J. Serum leptin level in women with polycystic ovary syndrome: correlation with adiposity, insulin, and circulating testosterone. Ann Med Health Sci Res. 2013;3(2):191–196.
   PubMedGoogle Scholar
• Crisosto N, Codner E, Maliqueo M, et al. Anti-Mullerian hormone levels in peripubertal daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2007;92(7):2739–2743.
   PubMed Web of Science ®Google Scholar
• Sir-Petermann T, Codner E, Maliqueo M, et al. Increased anti-Mullerian hormone serum concentrations in prepubertal daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91(8):3105–3109.
   PubMed Web of Science ®Google Scholar
• Sir-Petermann T, Codner E, Perez V, et al. Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2009;94(6):1923–1930.
   PubMed Web of Science ®Google Scholar
• Sir-Petermann T, Maliqueo M, Codner E, et al. Early metabolic derangements in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2007;92(12):4637–4642.
   PubMed Web of Science ®Google Scholar
• Recabarren SE, Sir-Petermann T, Rios R, et al. Pituitary and testicular function in sons of women with polycystic ovary syndrome from infancy to adulthood. J Clin Endocrinol Metab. 2008;93(9):3318–3324.
   PubMed Web of Science ®Google Scholar
• Recabarren SE, Smith R, Rios R, et al. Metabolic profile in sons of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2008;93(5):1820–1826.
   PubMed Web of Science ®Google Scholar
• Schuring AN, Welp A, Gromoll J, et al. Role of the CAG repeat polymorphism of the androgen receptor gene in polycystic ovary syndrome (PCOS). Exp Clin Endocrinol Diabetes. 2012;120(2):73–79.
   PubMed Web of Science ®Google Scholar
• Xita N, Georgiou I, Lazaros L, et al. The role of sex hormone-binding globulin and androgen receptor gene variants in the development of polycystic ovary syndrome. Hum Reprod. 2008;23(3):693–698.
   PubMed Web of Science ®Google Scholar
• Shah NA, Antoine HJ, Pall M, et al. Association of androgen receptor CAG repeat polymorphism and polycystic ovary syndrome. J Clin Endocrinol Metab. 2008;93(5):1939–1945.
   PubMed Web of Science ®Google Scholar
• Crisosto N, Echiburu B, Maliqueo M, et al. Improvement of hyperandrogenism and hyperinsulinemia during pregnancy in women with polycystic ovary syndrome: possible effect in the ovarian follicular mass of their daughters. Fertil Steril. 2012;97(1):218–224.
   PubMed Web of Science ®Google Scholar
• Luque-Ramírez M, San Millán JL, Escobar-Morreale HF. Genomic variants in polycystic ovary syndrome. Clin Chim Acta. 2006;366(1–2):14–26.
   PubMed Web of Science ®Google Scholar
• Escobar-Morreale HF, Luque-Ramirez M, San Millan JL. The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. Endocr Rev. 2005;26(2):251–282.
   PubMed Web of Science ®Google Scholar
• Hickey TE, Legro RS, Norman RJ. Epigenetic modification of the X chromosome influences susceptibility to polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91(7):2789–2791.
   PubMed Web of Science ®Google Scholar
• Gur EB, Karadeniz M, Turan GA. Fetal programming of polycystic ovary syndrome. World J Diabetes. 2015;6(7):936–942.
   PubMed Web of Science ®Google Scholar
• Christensen BC, Marsit CJ. Epigenomics in environmental health. Front Genet. 2011;2:84.
   PubMedGoogle Scholar
• Guerrero-Bosagna C, Skinner MK. Environmentally induced epigenetic transgenerational inheritance of phenotype and disease. Mol Cell Endocrinol. 2012;354(1–2):3–8.
   PubMed Web of Science ®Google Scholar
• Meer A, Mikkelsen TS, Gu H, et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature. 2008;454(7205):766–770.
   PubMed Web of Science ®Google Scholar
• Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002;16(1):6–21.
   PubMed Web of Science ®Google Scholar
• Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet. 2012;13(7):484–492.
   PubMed Web of Science ®Google Scholar
• Li Z, Huang H. Epigenetic abnormality: a possible mechanism underlying the fetal origin of polycystic ovary syndrome. Med Hypotheses. 2008;70(3):638–642.
   PubMed Web of Science ®Google Scholar
• Wang P, Zhao H, Li T, et al. Hypomethylation of the LH/choriogonadotropin receptor promoter region is a potential mechanism underlying susceptibility to polycystic ovary syndrome. Endocrinology. 2014;155(4):1445–1452.
   PubMed Web of Science ®Google Scholar
• Sang Q, Li X, Wang H, et al. Quantitative methylation level of the EPHX1 promoter in peripheral blood DNA is associated with polycystic ovary syndrome. PloS One. 2014;9(2):e88013.
   PubMed Web of Science ®Google Scholar
• Yu YY, Sun CX, Liu YK, et al. Promoter methylation of CYP19A1 gene in Chinese polycystic ovary syndrome patients. Gynecol Obstet Invest. 2013;76(4):209–213.
   PubMed Web of Science ®Google Scholar
• Wang XX, Wei JZ, Jiao J, et al. Genome-wide DNA methylation and gene expression patterns provide insight into polycystic ovary syndrome development. Oncotarget. 2014;5(16):6603–6610.
   PubMedGoogle Scholar
• Qu F, Wang FF, Yin R, et al. A molecular mechanism underlying ovarian dysfunction of polycystic ovary syndrome: hyperandrogenism induces epigenetic alterations in the granulosa cells. J Mol Med. 2012;90(8):911–923.
   PubMed Web of Science ®Google Scholar
• Pan JX, Tan YJ, Wang FF, et al. Aberrant expression and DNA methylation of lipid metabolism genes in PCOS: a new insight into its pathogenesis. Clin Epigenetics. 2018;10(1):6.
   PubMedGoogle Scholar
• Hickey T, Chandy A, Norman RJ. The androgen receptor CAG repeat polymorphism and X-chromosome inactivation in Australian Caucasian women with infertility related to polycystic ovary syndrome. J Clin Endocrinol Metab. 2002;87(1):161–165.
   PubMed Web of Science ®Google Scholar
• Houde AA, Hivert MF, Bouchard L. Fetal epigenetic programming of adipokines. Adipocyte. 2013;2(1):41–46.
   PubMedGoogle Scholar
• Wijaya AD, Febri RR, Desmawati, et al. DNA methylation analysis of anti-mullerian hormone gene in ovarian granulosa cells in PCOS patients. J Phys. 2018;1073:032077.
   Google Scholar
• Lambertini L, Saul SR, Copperman AB, et al. Intrauterine reprogramming of the polycystic ovary syndrome: evidence from a pilot study of cord blood global methylation analysis. Front Endocrinol (Lausanne). 2017;8:352.
   PubMed Web of Science ®Google Scholar
• Zawadzki JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif AGJ, Haseltine FP, Merriam GR, editors. Polycystic ovary syndrome. Oxford, UK: Blackwel; 1992. p. 59–69.
   Google Scholar
• Krueger F, Andrews SR. Bismark: a flexible aligner and methylation caller for bisulfite-seq applications. Bioinformatics. 2011;27(11):1571–1572.
   PubMed Web of Science ®Google Scholar
• Hertzberg L, Izraeli S, Domany E. STOP: searching for transcription factor motifs using gene expression. Bioinformatics. 2007;23(14):1737–1743.
   PubMed Web of Science ®Google Scholar
• Wroblewski A, Strycharz J, Swiderska E, et al. Molecular insight into the interaction between epigenetics and leptin in metabolic disorders. Nutrients. 2019;11(8):1872.
   Web of Science ®Google Scholar
• Lesseur C, Armstrong DA, Paquette AG, et al. Tissue-specific Leptin promoter DNA methylation is associated with maternal and infant perinatal factors. Mol Cell Endocrinol. 2013;381(1–2):160–167.
   PubMed Web of Science ®Google Scholar
• Nogues P, Dos Santos E, Jammes H, et al. Maternal obesity influences expression and DNA methylation of the adiponectin and leptin systems in human third-trimester placenta. Clin Epigenetics. 2019;11(1):20.
   PubMedGoogle Scholar
• Maliqueo M, Sundstrom Poromaa I, Vanky E, et al. Placental STAT3 signaling is activated in women with polycystic ovary syndrome. Hum Reprod. 2015;30(3):692–700.
   PubMed Web of Science ®Google Scholar
• Puttabyatappa M, Andriessen V, Mesquitta M, et al. Developmental programming: impact of gestational steroid and metabolic milieus on mediators of insulin sensitivity in prenatal testosterone-treated female sheep. Endocrinology. 2017;158(9):2783–2798.
   PubMed Web of Science ®Google Scholar
• Tobi EW, Lumey LH, Talens RP, et al. DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific. Hum Mol Genet. 2009;18(21):4046–4053.
   PubMed Web of Science ®Google Scholar
• Stoger R. In vivo methylation patterns of the leptin promoter in human and mouse. Epigenetics. 2006;1(4):155–162.
   PubMed Web of Science ®Google Scholar
• Melzner I, Scott V, Dorsch K, et al. Leptin gene expression in human preadipocytes is switched on by maturation-induced demethylation of distinct CpGs in its proximal promoter. J Biol Chem. 2002;277(47):45420–45427.
   PubMed Web of Science ®Google Scholar
• Garcia-Cardona MC, Huang F, Garcia-Vivas JM, et al. DNA methylation of leptin and adiponectin promoters in children is reduced by the combined presence of obesity and insulin resistance. Int J Obes (Lond). 2014;38(11):1457–1465.
   PubMed Web of Science ®Google Scholar
• Yousefi M, Karmaus W, Zhang H, et al. The methylation of the LEPR/LEPROT genotype at the promoter and body regions influence concentrations of leptin in girls and BMI at age 18 years if their mother smoked during pregnancy. Int J Mol Epidemiol Genet. 2013;4(2):86–100.
   PubMedGoogle Scholar
• Maliqueo M, Galgani JE, Perez-Bravo F, et al. Relationship of serum adipocyte-derived proteins with insulin sensitivity and reproductive features in pre-pubertal and pubertal daughters of polycystic ovary syndrome women. Eur J Obstet Gynecol Reprod Biol. 2012;161(1):56–61.
   PubMed Web of Science ®Google Scholar
• Heard E, Clerc P, Avner P. X-chromosome inactivation in mammals. Annu Rev Genet. 1997;31:571–610.
   PubMed Web of Science ®Google Scholar
• Echiburu B, Perez-Bravo F, Maliqueo M, et al. CAG repeat polymorphism of androgen receptor gene and X-chromosome inactivation in daughters of women with polycystic ovary syndrome (PCOS): relationship with endocrine and metabolic parameters. Gynecol Endocrinol. 2012;28(7):516–520.
   PubMed Web of Science ®Google Scholar
• Rajender S, Carlus SJ, Bansal SK, et al. Androgen receptor CAG repeats length polymorphism and the risk of polycystic ovarian syndrome (PCOS). PLoS One. 2013;8(10):e75709.
   PubMed Web of Science ®Google Scholar
• Dasgupta S, Sirisha PV, Neelaveni K, et al. Androgen receptor CAG repeat polymorphism and epigenetic influence among the south Indian women with polycystic ovary syndrome. PLoS One. 2010;5(8):e12401.
   PubMed Web of Science ®Google Scholar
• Ortega HH, Salvetti NR, Padmanabhan V. Developmental programming: prenatal androgen excess disrupts ovarian steroid receptor balance. Reproduction. 2009;137(5):865–877.
   PubMed Web of Science ®Google Scholar
• Hogg K, Wood C, McNeilly AS, et al. The in utero programming effect of increased maternal androgens and a direct fetal intervention on liver and metabolic function in adult sheep. PloS One. 2011;6(9):e24877.
   PubMed Web of Science ®Google Scholar
• Ammerpohl O, Bens S, Appari M, et al. Androgen receptor function links human sexual dimorphism to DNA methylation. PLoS One. 2013;8(9):e73288.
   PubMed Web of Science ®Google Scholar
• Moverare-Skrtic S, Mellstrom D, Vandenput L, et al. Peripheral blood leukocyte distribution and body mass index are associated with the methylation pattern of the androgen receptor promoter. Endocrine. 2009;35(2):204–210.
   PubMed Web of Science ®Google Scholar
• Vottero A, Capelletti M, Giuliodori S, et al. Decreased androgen receptor gene methylation in premature pubarche: a novel pathogenetic mechanism? J Clin Endocrinol Metab. 2006;91(3):968–972.
   PubMed Web of Science ®Google Scholar
• Lukas-Croisier C, Lasala C, Nicaud J, et al. Follicle-stimulating hormone increases testicular anti-mullerian hormone (AMH) production through sertoli cell proliferation and a nonclassical cyclic adenosine 5ʹ-monophosphate-mediated activation of the AMH gene. Mol Endocrinol. 2003;17(4):550–561.
   PubMedGoogle Scholar
• Fleisch AF, Wright RO, Baccarelli AA. Environmental epigenetics: a role in endocrine disease? J Mol Endocrinol. 2012;49(2):R61–7.
   PubMed Web of Science ®Google Scholar
• Gluckman PD, Hanson MA. Developmental and epigenetic pathways to obesity: an evolutionary-developmental perspective. Int J Obesity. 2008;32(Suppl 7):S62–71.
   PubMed Web of Science ®Google Scholar
• Elbere I, Silamikelis I, Ustinova M, et al. Significantly altered peripheral blood cell DNA methylation profile as a result of immediate effect of metformin use in healthy individuals. Clin Epigenetics. 2018;10(1):156.
   PubMedGoogle Scholar
• Rowan JA, Rush EC, Plank LD, et al. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7–9 years of age. BMJ Open Diabetes Res Care. 2018;6(1):e000456.
   PubMed Web of Science ®Google Scholar
• Hanem LGE, Stridsklev S, Juliusson PB, et al. Metformin use in PCOS pregnancies increases the risk of offspring overweight at 4 years of age: follow-up of two RCTs. J Clin Endocrinol Metab. 2018;103(4):1612–1621.
   PubMed Web of Science ®Google Scholar
• Hanem LGE, Salvesen O, Juliusson PB, et al. Intrauterine metformin exposure and offspring cardiometabolic risk factors (PedMet study): a 5–10 year follow-up of the PregMet randomised controlled trial. Lancet Child Adolesc Health. 2019;3(3):166–174.
   PubMedGoogle Scholar
• Weng X, Liu F, Zhang H, et al. Genome-wide DNA methylation profiling in infants born to gestational diabetes mellitus. Diabetes Res Clin Pract. 2018;142:10–18.
   PubMed Web of Science ®Google Scholar
• Houshmand-Oeregaard A, Hansen NS, Hjort L, et al. Differential adipokine DNA methylation and gene expression in subcutaneous adipose tissue from adult offspring of women with diabetes in pregnancy. Clin Epigenetics. 2017;9:37.
   PubMed Web of Science ®Google Scholar
• Senner CE. The role of DNA methylation in mammalian development. Reprod Biomed Online. 2011;22(6):529–535.
   PubMed Web of Science ®Google Scholar
• Gibney ER, Nolan CM. Epigenetics and gene expression. Heredity (Edinb). 2010;105(1):4–13.
   PubMed Web of Science ®Google Scholar
• Campanero MR, Armstrong MI, Flemington EK. CpG methylation as a mechanism for the regulation of E2F activity. Proc Natl Acad Sci U S A. 2000;97(12):6481–6486.
   PubMed Web of Science ®Google Scholar
• Comb M, Goodman HM. CpG methylation inhibits proenkephalin gene expression and binding of the transcription factor AP-2. Nucleic Acids Res. 1990;18(13):3975–3982.
   PubMed Web of Science ®Google Scholar
• Mancini DN, Singh SM, Archer TK, et al. Site-specific DNA methylation in the neurofibromatosis (NF1) promoter interferes with binding of CREB and SP1 transcription factors. Oncogene. 1999;18(28):4108–4119.
   PubMed Web of Science ®Google Scholar
• Yin H, Blanchard KL. DNA methylation represses the expression of the human erythropoietin gene by two different mechanisms. Blood. 2000;95(1):111–119.
   PubMed Web of Science ®Google Scholar
• Gu P, Le Menuet D, Chung AC, et al. Differential recruitment of methylated CpG binding domains by the orphan receptor GCNF initiates the repression and silencing of Oct4 expression. Mol Cell Biol. 2006;26(24):9471–9483.
   PubMed Web of Science ®Google Scholar
• Chen J, Meng Y, Zhou J, et al. Identifying candidate genes for Type 2 Diabetes Mellitus and obesity through gene expression profiling in multiple tissues or cells. J Diabetes Res. 2013;2013:970435.
   PubMed Web of Science ®Google Scholar
• Kokosar M, Benrick A, Perfilyev A, et al. A single bout of electroacupuncture remodels epigenetic and transcriptional changes in adipose tissue in polycystic ovary syndrome. Sci Rep. 2018;8(1):1878.
   PubMedGoogle Scholar
• Brey CW, Nelder MP, Hailemariam T, et al. Kruppel-like family of transcription factors: an emerging new frontier in fat biology. Int J Biol Sci. 2009;5(6):622–636.
   PubMed Web of Science ®Google Scholar
• Roy D, Farabaugh KT, Wu J, et al. Coordinated transcriptional control of adipocyte triglyceride lipase (Atgl) by transcription factors Sp1 and peroxisome proliferator-activated receptor gamma (PPARgamma) during adipocyte differentiation. J Biol Chem. 2017;292(36):14827–14835.
   PubMed Web of Science ®Google Scholar
• Liao X, Sharma N, Kapadia F, et al. Kruppel-like factor 4 regulates macrophage polarization. J Clin Invest. 2011;121(7):2736–2749.
   PubMed Web of Science ®Google Scholar
• Yang SZ, Abdulkadir SA. Early growth response gene 1 modulates androgen receptor signaling in prostate carcinoma cells. J Biol Chem. 2003;278(41):39906–39911.
   PubMed Web of Science ®Google Scholar
• Gonzalez F, Kirwan JP, Rote NS, et al. Glucose ingestion stimulates atherothrombotic inflammation in polycystic ovary syndrome. Am J Physiol Endocrinol Metab. 2013;304(4):E375–83.
   PubMed Web of Science ®Google Scholar
• Yin M, Wang X, Yao G, et al. Transactivation of micrornA-320 by microRNA-383 regulates granulosa cell functions by targeting E2F1 and SF-1 proteins. J Biol Chem. 2014;289(26):18239–18257.
   PubMed Web of Science ®Google Scholar
• Liu G, Sprenger C, Wu PJ, et al. MED1 mediates androgen receptor splice variant induced gene expression in the absence of ligand. Oncotarget. 2015;6(1):288–304.
   PubMedGoogle Scholar
• Das M, Djahanbakhch O, Hacihanefioglu B, et al. Granulosa cell survival and proliferation are altered in polycystic ovary syndrome. J Clin Endocrinol Metab. 2008;93(3):881–887.
   PubMed Web of Science ®Google Scholar
• Salvetti NR, Ortega HH, Veiga-Lopez A, et al. Developmental programming: impact of prenatal testosterone excess on ovarian cell proliferation and apoptotic factors in sheep1. Biol Reprod. 2012;87(1). DOI:10.1095/biolreprod.112.100024
   PubMed Web of Science ®Google Scholar
• Babu KA, Rao KL, Kanakavalli MK, et al. CYP1A1, GSTM1 and GSTT1 genetic polymorphism is associated with susceptibility to polycystic ovaries in South Indian women. Reprod Biomed Online. 2004;9(2):194–200.
   PubMed Web of Science ®Google Scholar
• Zandarashvili L, White MA, Esadze A, et al. Structural impact of complete CpG methylation within target DNA on specific complex formation of the inducible transcription factor Egr-1. FEBS Lett. 2015;589(15):1748–1753.
   PubMed Web of Science ®Google Scholar
• Cole E, Brown TA, Pinkerton KE, et al. Perinatal exposure to environmental tobacco smoke is associated with changes in DNA methylation that precede the adult onset of lung disease in a mouse model. Inhal Toxicol. 2017;29(10):435–442.
   PubMed Web of Science ®Google Scholar
• Kanwal R, Gupta K, Gupta S. Cancer epigenetics: an introduction. Methods Mol Biol. 2015;1238:3–25.
   PubMedGoogle Scholar
• Teruel M, Sawalha AH. Epigenetic variability in systemic lupus erythematosus: what we learned from genome-wide DNA methylation studies. Curr Rheumatol Rep. 2017;19(6):32.
   PubMed Web of Science ®Google Scholar
• Li S, Zhu D, Duan H, et al. Differential DNA methylation patterns of polycystic ovarian syndrome in whole blood of Chinese women. Oncotarget. 2016;8(13):20656–20666.
   Google Scholar
• Sang Q, Zhang S, Zou S, et al. Quantitative analysis of follistatin (FST) promoter methylation in peripheral blood of patients with polycystic ovary syndrome. Reprod Biomed Online. 2013;26(2):157–163.
   PubMed Web of Science ®Google Scholar
• Houde -A-A, Légaré C, Hould F-S, et al. Cross-tissue comparisons of leptin and adiponectin: DNA methylation profiles. Adipocyte. 2014;3(2):132–140.
   PubMedGoogle Scholar
• VA-m ER, Gomez-Viais YI, Garcia-Gomez E, et al. DNA methylation in the pathogenesis of polycystic ovary syndrome. Reproduction. 2019;158(1):R27–R40.
   Google Scholar
• Slieker RC, Bos SD, Goeman JJ, et al. Identification and systematic annotation of tissue-specific differentially methylated regions using the Illumina 450k array. Epigenetics Chromatin. 2013;6(1):26.
   PubMedGoogle Scholar
• Ma B, Wilker EH, Willis-Owen SA, et al. Predicting DNA methylation level across human tissues. Nucleic Acids Res. 2014;42(6):3515–3528.
   PubMed Web of Science ®Google Scholar